Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Oncology Center of Excellence

Oncology Center of Excellence

                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community Home
          About FDA
          FDA Organization
          Oncology Center of Excellence
          Project CatalystOncology Center of Excellence Project Catalyst
  
  					Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation
	
    Share
    Post
    Linkedin

    Email
    PrintImage
              Project CatalystAdvances in science and technology, and an evolving academic environment, have accelerated the growth of start-up companies developing anticancer therapies. With the increasing numbers of small innovative companies emerging from academia, the Oncology Center of Excellence **Project Catalyst** was developed.

Working primarily with small pharmaceutical companies and academic life science incubators and accelerators, Project Catalyst provides guidance and educational resources that help support informed anticancer therapy development to expedite the availability of directed and novel cancer treatments to the public.

Accelerator Innovator Discussion (AID) Meetings

Project Catalyst can facilitate “Speed Dating” like interactions with Project Teams at your Academic Accelerators and Life Science Hubs through virtual meetings, allowing investigators to ask questions regarding their drug development plans at an early stage prior to a Pre-IND Meeting. Contact Project Catalyst at **OCE-Catalyst@fda.hhs.gov** for more information and to coordinate a session.

Oncology Regulatory Expertise and Early Guidance (OREEG)

Project Catalyst’s educational initiative entitled **Oncology Regulatory Expertise and Early Guidance (OREEG)** is a self-directed platform providing early-stage oncology companies with product-type advice to inform sound product-specific drug development decisions.

Meetings and Workshops

August 24, 2023: **FNIH, NCI, and FDA Public Meeting**—**Creating a Public-Private Partnership to Support Development of Anti-Cancer Therapies for Ultra-Rare Tumor Indications**. Visit the link to review meeting materials and summary. Watch on YouTube.Project Leaders:

Marc R. Theoret, MD, Deputy Director, Oncology Center of Excellence
Jeff Summers, MD, Associate Director Translational Sciences, Office Oncologic Drugs

**Please send your questions and information to Jeffery Summers at:OCE-Catalyst@fda.hhs.gov**

Additional Information:

FDA Oncology Center of ExcellenceCDER Small Business & Industry Assistance (SBIA)

Twitter: #OCECatalyst

                                                                                  Content current as of:
      11/01/2023Oncology Center of Excellence

          
                        Who We Are - Oncology Center of Excellence
          Project Patient Voice


                        OCE Annual Reports
          Project Community
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop